ArticleTranslational oncology2012

Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist.

Sun-Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.